What is PD Holdings?
PD Holdings operates within the pharmaceutical services sector, focusing on advanced manufacturing and development. The company's expertise lies in specialized technologies such as spray drying, amorphous solid dispersions, and particle engineering, offering a comprehensive suite of services to clients in the pharmaceutical, consumer health, OTC, and nutraceutical industries. With established manufacturing capabilities in the US and UK, PD Holdings is recognized for its adherence to stringent regulatory standards and its commitment to delivering high-quality solutions that enhance product bioavailability and manufacturing efficiency.
How much funding has PD Holdings raised?
PD Holdings has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in PD Holdings
PPP
Public-Private Partnership
What's next for PD Holdings?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated expansion and innovation for PD Holdings. This capital infusion is expected to fuel further development of their specialized CDMO services, potentially enabling the company to scale its operations, enhance its technological capabilities, and broaden its market reach. Strategic partnerships and continued investment in research and development will likely be key to solidifying PD Holdings' position as a leader in pharmaceutical manufacturing and development.
See full PD Holdings company page
